Urothelial ATP Signaling and Diabetic Bladder Dysfunction
尿路上皮 ATP 信号转导和糖尿病性膀胱功能障碍
基本信息
- 批准号:8287637
- 负责人:
- 金额:$ 28.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBiochemistryBladderBladder DiseasesBladder DysfunctionBladder UrotheliumCommunicationDevelopmentDiabetes MellitusDinoprostoneFiberGoalsImageIn VitroLeadMediatingMembraneMicturition ReflexMolecular BiologyMotorMyofibroblastNerve FibersPathway interactionsPharmacologyPhysiologyPlayProstaglandinsProteinsPurinoceptorRelative (related person)RoleSensorySignal PathwaySignal TransductionSignaling MoleculeSmooth MuscleSmooth Muscle MyocytesStreptozocinSymptomsSystemTestingUp-RegulationUrodynamicsUrothelial CellUrotheliumafferent nervebasedesigndetrusor musclediabeticdiabetic ratintercellular communicationnew therapeutic targetnovelreceptorresearch studyresponse
项目摘要
ATP plays important roles in the sensory and motor functions of the urinary bladder. ATP
released from parasympathetic fibers can excite the detrusor muscle, and ATP released from the
urothelium in response to bladder distension can indirectly modulate detrusor contractility by activating
afferent fibers, stimulating suburothelial myofibroblasts and inducing release of other signaling molecules
from the urothelium. Pathological conditions can increase the purinergic component of the neurogenic
detrusor contraction and also augment urothelial ATP release. In diabetes various urodynamic
abnormalities can develop, including increased bladder activity. We have proposed that increased
sensitivity of diabetic bladders to purinergic stimulation was related to upregulation of specific purinergic
receptor (P2R) subtypes in the detrusor muscle, and that amplification of ATP signaling would directly
contribute to the development of bladder overactivity in diabetes. Based on recent findings we have now
evidence that ATP signaling in also amplified in the diabetic bladder urothelium. Expression of P2Rs,
particularly the P2X7R and P2X3R subtypes, is markedly increased in the urothelium of STZ-diabetic rat
bladders and responses to ATP are higher in STZ-diabetic urothelial cells. These findings combined with
demonstrations that P2X7R activation can induce release of both ATP and prostaglandin (PGE2),
suggest that not only the sensitivity to ATP but also ATP and PGE2 release from urothelial cells is
increased in diabetic bladders. In this context, afferent signaling from the bladder as well as ability of
urothelial cells, suburothelial myofibroblast and smooth muscle cells to communicate would be
significantly enhanced and likely contribute to increase bladder activity in diabetes. To test the
hypotheses that diabetes increases urothelial ATP signaling and communication between bladder
compartments, and that enhanced ATP signaling within and from the bladder contributes to the
development of bladder dysfunction in diabetes we will use a combination of molecular biology,
biochemistry, pharmacology, in vitro subcellular imaging and whole animal physiology approaches.
These studies are expected to lead to novel understanding of the interplay among specific membrane
receptors and channel proteins involved in intercellular signaling between urothelium and bladder smooth
muscle, and reveal novel therapeutic targets and strategies to ameliorate the symptoms of bladder
dysfunction in diabetes.
ATP在膀胱的感觉和运动功能中起着重要作用。 ATP
从副交感纤维中释放的可以激发逼尿肌的肌肉,然后从
响应膀胱膨胀的尿铺上皮可以通过激活而间接调节损害收缩性
传入纤维,刺激层肌纤维细胞并诱导其他信号分子的释放
来自尿路上皮。病理条件可以增加神经源的嘌呤能成分
迫切收缩,还增加尿路上皮ATP的释放。在糖尿病中各种尿动力学
异常可以发展,包括增加膀胱活性。我们建议增加
糖尿病性膀胱对嘌呤能刺激的敏感性与特定嘌呤能的上调有关
受体(P2R)亚型中的肌肉中的亚型,ATP信号的扩增将直接
有助于糖尿病中膀胱过度活动的发展。根据最近的发现,我们现在有
ATP信号传导也在糖尿病膀胱尿路上皮中得到扩增的证据。 p2rs的表达
特别是P2X7R和P2X3R亚型,在STZ-糖尿病大鼠的尿皮细胞中明显增加
在STZ糖尿病尿路上皮细胞中,膀胱和对ATP的反应更高。这些发现与
证明P2X7R激活可以诱导ATP和前列腺素的释放(PGE2),
建议不仅对ATP的敏感性,而且还从尿路上皮细胞中释放ATP和PGE2的敏感性是
糖尿病性膀胱增加。在这种情况下,来自膀胱的传入信号以及能力
尿路上皮细胞,层肌纤维细胞和平滑肌细胞进行交流将是
显着增强并可能有助于增加糖尿病的膀胱活性。测试
假设糖尿病会增加尿路上皮ATP信号传导和膀胱之间的通信
车厢,并增强了膀胱内外的ATP信号传导有助于
糖尿病中膀胱功能障碍的发展我们将使用分子生物学的组合,
生物化学,药理学,体外亚细胞成像和整个动物生理学方法。
预计这些研究将导致对特定膜之间相互作用的新了解
受体和通道蛋白涉及尿路上皮和膀胱之间的细胞间信号传导
肌肉,并揭示新的治疗靶标和策略以改善膀胱症状
糖尿病功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SYLVIA OTTILIE SUADICANI其他文献
SYLVIA OTTILIE SUADICANI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SYLVIA OTTILIE SUADICANI', 18)}}的其他基金
Role of neuron-satellite glia cell signaling in pelvic pain and visceral cross-sensitization
神经卫星胶质细胞信号传导在盆腔疼痛和内脏交叉敏化中的作用
- 批准号:
10837287 - 财政年份:2023
- 资助金额:
$ 28.47万 - 项目类别:
Pannexin 1 channels, new players in diabetic bladder dysfunction
Pannexin 1 通道,糖尿病膀胱功能障碍的新参与者
- 批准号:
10078231 - 财政年份:2019
- 资助金额:
$ 28.47万 - 项目类别:
Pannexin 1 channels, new players in diabetic bladder dysfunction
Pannexin 1 通道,糖尿病膀胱功能障碍的新参与者
- 批准号:
9803135 - 财政年份:2019
- 资助金额:
$ 28.47万 - 项目类别:
Pannexin 1 channels, new players in diabetic bladder dysfunction
Pannexin 1 通道,糖尿病膀胱功能障碍的新参与者
- 批准号:
10202586 - 财政年份:2019
- 资助金额:
$ 28.47万 - 项目类别:
Pannexin 1 channels, new players in diabetic bladder dysfunction
Pannexin 1 通道,糖尿病膀胱功能障碍的新参与者
- 批准号:
10427295 - 财政年份:2019
- 资助金额:
$ 28.47万 - 项目类别:
Urothelial ATP Signaling and Diabetic Bladder Dysfunction
尿路上皮 ATP 信号转导和糖尿病性膀胱功能障碍
- 批准号:
7810752 - 财政年份:2009
- 资助金额:
$ 28.47万 - 项目类别:
Urothelial ATP Signaling and Diabetic Bladder Dysfunction
尿路上皮 ATP 信号转导和糖尿病性膀胱功能障碍
- 批准号:
8459020 - 财政年份:2009
- 资助金额:
$ 28.47万 - 项目类别:
Urothelial ATP Signaling and Diabetic Bladder Dysfunction
尿路上皮 ATP 信号转导和糖尿病性膀胱功能障碍
- 批准号:
7651895 - 财政年份:2009
- 资助金额:
$ 28.47万 - 项目类别:
Urothelial ATP Signaling and Diabetic Bladder Dysfunction
尿路上皮 ATP 信号转导和糖尿病性膀胱功能障碍
- 批准号:
8069339 - 财政年份:2009
- 资助金额:
$ 28.47万 - 项目类别:
相似国自然基金
独特二聚天然产物Phomoxanthone A 生物合成关键酶学机制研究及衍生物化学酶法构建
- 批准号:32370056
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
施氮与混交对降香黄檀—沉香树植物−土壤−微生物化学计量的影响
- 批准号:32360366
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于生物化学与稳定同位素的达里湖水内外源补排机制及演化历史重构
- 批准号:52369014
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
亚洲落叶松八齿小蠹信息素的生物合成及JHIII调控机制
- 批准号:32371896
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
真菌漆酶驱动根际腐殖化减低粪肥源雌激素作物吸收的生物化学机理
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Neuron-specific nanotherapeutics for spinal cord injury repair
用于修复脊髓损伤的神经元特异性纳米疗法
- 批准号:
10352315 - 财政年份:2019
- 资助金额:
$ 28.47万 - 项目类别:
Adenylyl cyclase isoforms in collecting duct physiology and pathophysiology
腺苷酸环化酶亚型在集合管生理学和病理生理学中的作用
- 批准号:
8538228 - 财政年份:2013
- 资助金额:
$ 28.47万 - 项目类别:
Role of adenylyl cyclase isoforms in collecting duct physiology & pathophysiology
腺苷酸环化酶亚型在集合管生理学中的作用
- 批准号:
8574876 - 财政年份:2013
- 资助金额:
$ 28.47万 - 项目类别:
Role of adenylyl cyclase isoforms in collecting duct physiology & pathophysiology
腺苷酸环化酶亚型在集合管生理学中的作用
- 批准号:
8895765 - 财政年份:2013
- 资助金额:
$ 28.47万 - 项目类别: